Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes

Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes

Abstract Background Understanding the impact of different immunoglobulin (Ig) infusion methods (intravenous [IVIg] and subcutaneous [SCIg]) upon treatment experience can potentially facilitate optimization of patient outcomes. Here, the perspective of patients with primary and secondary immunodefici...

Full description

Bibliographic Details
Main Authors: Rajiv Mallick, Geneviève Solomon, Paul Bassett, Xiang Zhang, Palak Patel, Oleksandra Lepeshkina
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Immunodeficiency
Infusion method
Intravenous immunoglobulin (IVIg)
Subcutaneous immunoglobulin (SCIg)
Patient-reported outcomes
Treatment satisfaction questionnaire for medication 9 (TSQM-9)
Online Access:https://doi.org/10.1186/s13223-022-00746-3

Internet

https://doi.org/10.1186/s13223-022-00746-3

Similar Items